ŠRÁMKOVÁ, Taťána, Igor MOTIL, Jiří JARKOVSKÝ and Kateřina ŠRÁMKOVÁ. Erectile Dysfunction Treatment Using Focused Linear Low-Intensity Extracorporeal Shockwaves: Single-Blind, Sham-Controlled, Randomized Clinical Trial. Urologia Internationalis. Basel: Karger, 2020, vol. 104, 5-6, p. 417-424. ISSN 0042-1138. Available from: https://dx.doi.org/10.1159/000504788.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Erectile Dysfunction Treatment Using Focused Linear Low-Intensity Extracorporeal Shockwaves: Single-Blind, Sham-Controlled, Randomized Clinical Trial
Authors ŠRÁMKOVÁ, Taťána (203 Czech Republic, guarantor, belonging to the institution), Igor MOTIL (203 Czech Republic), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution) and Kateřina ŠRÁMKOVÁ (203 Czech Republic).
Edition Urologia Internationalis, Basel, Karger, 2020, 0042-1138.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30217 Urology and nephrology
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.089
RIV identification code RIV/00216224:14110/20:00115341
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1159/000504788
UT WoS 000543544500014
Keywords in English Erectile dysfunction; Cardiovascular disease; Low-intensity extracorporeal shockwave; Phosphodiesterase-5 inhibitors
Tags 14110711, 14119612, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 31/8/2020 12:18.
Abstract
Introduction:Low-intensity extracorporeal shock wave therapy (Li-ESWT) is a new treatment modality for erectile dysfunction (ED). Our aim was to evaluate the treatment outcome of Li-ESWT for ED in single-blind, placebo controlled, randomized clinical trial.Methods:Sixty patients were randomized into 2 age-matched groups: Group A - treatment and Group B - placebo. Treatment consisted of 4 sessions on the PiezoWave2 unit (R. Wolf and ELvation Medical). Effectiveness was assessed according to the International Index of Erectile Function 5 (IIEF-5), Erectile Hardness Score (EHS), questions 2 and 3 of the Sexual Encounter Profile (SEP 2, SEP 3), and Global Assessment Question (GAQ) scores at baseline and 4 and 12 weeks after treatment. We evaluated patient's and partner's subjective satisfaction.Results:A statistically significant difference between the groups was found at 4 and 12 weeks after treatment with regard to the quality of erection as measured by the IIEF-5 (p= 0.049 andp< 0.001, respectively), the EHS after week 12 (p< 0.001), an increase in the EHS after 4 and 12 weeks (p= 0.030 andp< 0.001, respectively), after 12 weeks in GAQ (p< 0.001), SEP 2 (p= 0.05), SEP 3 (p< 0.001), and patient's satisfaction (p< 0.001) and partner's satisfaction (p< 0.001).Conclusions:The randomized single-blind study confirms that Li-ESWT significantly improves erectile function.
PrintDisplayed: 22/7/2024 20:20